BioAura LabsResearch Vials
RESEARCH VIALS BIOAURA LABS
hGH Frag 176-191
A C-terminal fragment for sequence-focused research.
hGH Frag 176-191 is a peptide-fragment designation derived from the C-terminal region of human growth hormone. BioAura lists 5 mg and 10 mg vial presentations for laboratory research.
For laboratory research use only.
Not for human or veterinary use.
5 mg / 10 mg · Vials
SELECT YOUR PRESENTATION Catalog preview
TECHNICAL OVERVIEW
A C-terminal fragment for sequence-focused research.
Fragment studies examine selected regions of a larger protein to investigate sequence-dependent biochemical behavior. The 176–191 designation identifies the region of interest rather than describing full-length growth hormone.
The exact supplied sequence, terminal chemistry, and any modification should be confirmed before comparing materials. In particular, literature about a modified analogue should not be used as proof of the properties of an unmodified fragment.
RESEARCH CONTEXT
Comparative biochemical characterization
Fragment stability and analytical profiling
Specifications
- Catalog identity
- hGH Frag 176-191
- Research classification
- Synthetic peptide · Growth-hormone fragment
- Available presentations
- 5 mg / 10 mg · Vials
- Intended use
- For laboratory research use only. Not for human or veterinary use. Not for consumption or administration.
- Quantity interpretation
- Listed amounts identify catalog presentations, not doses. Confirm the content basis in the supplier specification.
- Identity and formulation
- Product identity, physical form, composition, analytical results, and supplier handling specifications must be matched to the BioAura lot.
- Lot-specific analytical results
- Pending. No purity, potency, sterility, endotoxin, or third-party testing claim is verified for this preview.
- Storage and stability
- Pending supplier instructions. No storage temperature, shelf life, or opened-container period is assigned.
Documentation & material status
Lot-specific records have not been supplied for this preview. Product imagery and general research literature do not establish the properties of a BioAura lot.
SPECTechnical specificationPending supplier verification
Product identity, physical form, composition, analytical results, and supplier handling specifications must be matched to the BioAura lot.
COACertificate of analysisLot-matched COA pending
Review the matching lot identifier, analytical methods, acceptance criteria, measured results, units, and issuing laboratory. A purity percentage alone does not establish content, identity, or suitability.
SDSSafety & handling recordsSupplier documentation pending
Obtain the relevant safety data, handling precautions, storage conditions, stability information, and disposal requirements before laboratory work.
PRODUCT QUESTIONS
Frequently Asked Questions
Is this full-length human growth hormone?
No. The catalog designation refers to a fragment. Exact sequence and chemical form remain subject to supplier confirmation.
What does the listed presentation tell me?
5 mg / 10 mg · Vials. These are supplied catalog details. They do not specify an experimental concentration, dose, preparation procedure, or administration instruction.
Is this intended for human or veterinary use?
For laboratory research use only. Not for human or veterinary use. Not for consumption or administration. This page provides no treatment, dosing, reconstitution, or administration guidance.
Can I purchase through this preview?
No. Prices and shopping-bag interactions demonstrate the proposed store experience. Final prices, availability, shipping, and payment processing have not been activated.
CONTINUE EXPLORING